Company: MBIO
Filing Date: 2025-01-15
Form Type: S-1
Source: 0001410578-25-000028
Chunk: 298

Company: MUSTANG BIO, INC.
Filing Date: 2025-01-15
Form: S-1
Chunk 298
---
638shares of common stock and (y) new Series B-2 Warrants to purchase 16,877,638shares of common stock (collectively, the “New Warrants”). In addition, we issued to Wainwright or its designees placement agent warrants to purchase 1,012,658shares of common stock. The placement agent warrants have the same terms as the Series B-1 Warrants, except that the placement agent warrants have an exercise price equal to $0.2963 per share. The transactions contemplated by the Inducement Letter closed on October 25, 2024. We received aggregate gross proceeds of approximately $4 million from the exercise of the Existing Warrants by the investor, before deducting placement agent fees and other expenses payable by us. The New Warrants were offered and sold in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act. The investor also represented that it qualified as an “accredited investor” within the meaning of Rule 501 of Regulation D. Item 16. Exhibits and financial statement schedules.

| (a) | Exhibits. |

The exhibits listed below are filed as part of this registration statement. The exhibits to the Registration Statement are listed in the Exhibit Index attached hereto and incorporated by reference herein.

| Exhibit No. |     | Description                                                                                                                                                                                                                                                                                                                                                                                                  |     | Form |     | File      
 Number    |     | Date              |     | Exhibit No. |     | Filed    
 Herewith |
| 1.1         |     | At Market Issuance Sales Agreement, dated July 27, 2018, between the Company, B. Riley FBR, Inc., Cantor Fitzgerald & Co., National Securities Corporation, and Oppenheimer & Co. Inc.                                                                                                                                                                                                                       |     | 8-K  |     | 001-38191 |     | July 27, 2018     |     |         1.1 |     |          |
| 1.2         |     | Amendment No. 1 to At Market Issuance Sales Agreement, dated July 20, 2020, between the Company, B. Riley FBR, Inc., Cantor Fitzgerald & Co., National Securities Corporation and Oppenheimer & Co. Inc.                                                                                                                                                                                                     |     | 8-K  |     | 001-38191 |     | July 24, 2020     |     |         1.2 |     |          |
|